Dasatinib-loaded albumin nanoparticles possess diminished endothelial cell barrier disruption and retain potent anti-leukemia cell activity

Chunling Dong(Second Affiliated Hospital of Jilin University), Jian Fu(Hubei University of Medicine)
Oncotarget
July 6, 2016
Cited by 28


Related Papers